# Outcomes and Prognostic Factors of Intravitreal Bevacizumab Monotherapy in Zone I Stage 3+ and Aggressive Posterior Retinopathy of Prematurity

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/outcomes-and-prognostic-factors-of-intravitreal-bevacizumab-monotherapy-in-zone/

## Facts

| Field | Value |
| --- | --- |
| Author Names | S Nicoară,C Nascutzy,Cristina Cristian,Iulian Irimescu,Anne Claudia Ştefănuţ,Gabriela Zaharie,Tudor Drugan |
| Citations | 29 |
| DOI | 10.1155/2015/102582 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://downloads.hindawi.com/journals/joph/2015/102582.pdf |
| OpenAlex ID | https://openalex.org/W1945264609 |
| PMID | 26491545 |
| Type | article |
| Year | 2015 |

## Paper authors

- [S Nicoară](https://scholariq.org/researchers/s-nicoara/)

## Paper journal

- [Journal of Ophthalmology](https://scholariq.org/journals/journal-of-ophthalmology/)

## Paper primary topic

- [Retinopathy of Prematurity Studies](https://scholariq.org/topics/retinopathy-of-prematurity-studies/)

## Paper topics

- [Retinopathy of Prematurity Studies](https://scholariq.org/topics/retinopathy-of-prematurity-studies/)
- [Neonatal Health and Biochemistry](https://scholariq.org/topics/neonatal-health-and-biochemistry/)
- [Retinal Diseases and Treatments](https://scholariq.org/topics/retinal-diseases-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.